PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, 10065, USA.\', \'Institute of Pathogen Biology and Center for AIDS Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.\', \'Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, 10065, USA; Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China. Electronic address: sjiang@nybc.org.\', \'Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, 10065, USA. Electronic address: ldu@nybc.org.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0166-3542(20)30234-510.1016/j.antiviral.2020.104820
?:hasPublicationType
?:journal
  • Antiviral research
is ?:pmid of
?:pmid
?:pmid
  • 32405117
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.925
?:rankingScore_hIndex
  • 105
is ?:relation_isRelatedTo_publication of
?:title
  • Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all